Moscow continues to develop the practice of offset contracts, which involve the purchase of goods for state needs with counter investment obligations to localize production. The 4th offset contract was signed in the food industry last summer. The investor was Wimm-Bill-Dann. The contract subject is baby food for the city's infant feeding centers. The company will produce 38 types of products: milk, juices, fruit, vegetable, meat and meat-plant puree, porridges, cottage cheese, kefir, sour milk and dry mixes. The city will purchase food for eight years since 2022. Private investment in the project will amount to RUB 2.1 bn. The volume of baby food supply to the city will be RUB 30.6 bn.
The 5th offset contract was signed on February 15, 2021. The investor - Moscow Endocrine Plant - will localize the production of 20 drugs in Moscow within two years. The plant will produce anti-glaucoma, antibacterial, analgesic drugs, antidepressants and neuroleptics, which will be purchased by the Moscow Government under an offset contract worth RUB 1.1 bn over 8 years. The planned investments will amount to RUB 1 bn.
The total volume of the five Moscow offset contracts is RUB 72.7 bn, and the cumulative volume of private investment reaches RUB 12.9 bn.